Vertex Pharmaceuticals Q3 Adj. EPS $4.76 Misses $4.82 Estimate, Sales $3.441B Beat $3.417B Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsHotEarnings BeatsEarnings Misses
Vertex Pharmaceuticals (NASDAQ:VRTX) reported quarterly earnings of $4.76 per share which missed the analyst consensus estimate of $4.82 by 1.24 percent. This is a 0.83 percent decrease over earnings of $4.80 per share
Vertex Pharmaceuticals (NASDAQ:VRTX) reported quarterly earnings of $4.76 per share which missed the analyst consensus estimate of $4.82 by 1.24 percent. This is a 0.83 percent decrease over earnings of $4.80 per share from the same period last year. The company reported quarterly sales of $3.441 billion which beat the analyst consensus estimate of $3.417 billion by 0.70 percent. This is a 11.87 percent increase over sales of $3.076 billion the same period last year.